股票 › RVMD
革命医药 RVMD
美股市值排名 #525
$192.28 +$14.63 (+8.24%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $194.38 +1.09%
开盘$184.87
昨收$177.65
当日区间$181.27 – $195.02
成交量4.50M
市值$41.59B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$505.13M-90.8% YoY
净利润-$644.37M-160.1% YoY
摊薄每股收益-$3.06-133.6% YoY
自由现金流-$745.31M-225.2% YoY
经营现金流-$741.48M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-79.1%
资产收益率-52.4%
投入资本回报率-68.9%
流动比率11.38
负债/资产比率39.7%
现金及投资$3.94B
总负债$625.18M
净现金（净负债）$3.31B
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $505.13M | $445.22M | $1.18B | $361.63M | $315.27M |
| 销售及管理费用 | $110.21M | $101.25M | $195.04M | $66.68M | $52.76M |
| -管理费用 | $110.21M | $101.25M | $195.04M | $66.68M | $52.76M |
| 研发费用 | $394.92M | $343.97M | $987.33M | $294.94M | $262.51M |
| 营业利润 | -$505.13M | -$445.22M | -$1.18B | -$361.63M | -$315.27M |
| 非经营性利息净收入（支出） | $11.80M | $7.31M | $66.46M | $9.36M | $10.66M |
| 非经营性利息收入 | $35.58M | $19.51M | $90.69M | $21.29M | $22.08M |
| 非经营性利息支出 | $23.78M | $12.20M | $24.23M | $11.94M | $11.43M |
| 其他收入（支出） | -$151.04M | -$15.91M | -$15.40M | -$12.62M | -$592,000.00 |
| 证券出售收益 | -$151.03M | -$15.79M | -$15.36M | -$12.63M | -$592,000.00 |
| 其他非经营性收入（支出） | -$6,000.00 | -$117,000.00 | -$37,000.00 | $5,000.00 | – |
| 税前利润 | -$644.37M | -$453.82M | -$1.13B | -$364.89M | -$305.21M |
| 净利润 | -$644.37M | -$453.82M | -$1.13B | -$364.89M | -$305.21M |
| 持续经营利润 | -$644.37M | -$453.82M | -$1.13B | -$364.89M | -$305.21M |
| 归属母公司净利润 | -$644.37M | -$453.82M | -$1.13B | -$364.89M | -$305.21M |
| 归属普通股股东净利润 | -$644.37M | -$453.82M | -$1.13B | -$364.89M | -$305.21M |
| 基本每股收益 | -$3.06 | -$2.29 | -$5.95 | -$1.86 | -$1.61 |
| 摊薄每股收益 | -$3.06 | -$2.29 | -$5.95 | -$1.86 | -$1.61 |
| 报告营业总收入 | – | – | $0.00 | $0.00 | $0.00 |
| 税费 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $4.32B | $2.25B | $2.35B | $2.35B | $2.25B |
| 流动资产合计 | $4.03B | $1.97B | $2.08B | $2.08B | $1.98B |
| 现金及现金等价物与短期投资 | $3.94B | $1.91B | $2.03B | $2.03B | $1.93B |
| -现金及现金等价物 | $815.44M | $440.94M | $383.75M | $383.75M | $217.44M |
| -短期投资 | $3.12B | $1.47B | $1.64B | $1.64B | $1.71B |
| 其他流动资产 | $90.37M | $59.83M | $49.36M | $49.36M | $45.98M |
| 非流动资产合计 | $294.93M | $285.82M | $279.47M | $279.47M | $274.43M |
| 固定资产净值 | $162.45M | $161.37M | $165.28M | $165.28M | $167.38M |
| -固定资产原值 | $195.29M | $192.05M | $193.79M | $193.79M | $194.39M |
| -累计折旧 | -$32.84M | -$30.68M | -$28.51M | -$28.51M | -$27.01M |
| 一年以上预付资产 | $42.45M | $34.71M | $24.15M | $24.15M | $16.85M |
| 商誉及其他无形资产 | $70.41M | $70.41M | $70.41M | $70.41M | $70.48M |
| -商誉 | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |
| -其他无形资产 | $55.80M | $55.80M | $55.80M | $55.80M | $55.87M |
| 其他非流动资产 | $19.62M | $19.34M | $19.64M | $19.64M | $19.73M |
| 负债合计 | $1.72B | $753.82M | $723.21M | $723.21M | $655.02M |
| 流动负债合计 | $354.06M | $289.60M | $290.42M | $290.42M | $245.62M |
| 应付款 | $88.42M | $80.54M | $64.62M | $64.62M | $74.85M |
| -应付账款 | $88.42M | $80.54M | $64.62M | $64.62M | $74.85M |
| 一年内应计费用 | $179.06M | $165.93M | $143.29M | $143.29M | $114.42M |
| 短期债务及融资租赁负债 | $16.75M | $16.61M | $16.47M | $16.47M | $16.33M |
| -一年内到期融资租赁负债 | $16.75M | $16.61M | $16.47M | $16.47M | $16.33M |
| 其他流动负债 | $5.15M | $3.26M | $7.86M | $7.86M | $8.24M |
| 非流动负债合计 | $1.36B | $464.22M | $432.79M | $432.79M | $409.39M |
| 长期债务及融资租赁负债 | $625.18M | $140.02M | $142.23M | $142.23M | $142.14M |
| -长期债务 | $487.43M | – | – | – | – |
| -长期融资租赁负债 | $137.74M | $140.02M | $142.23M | $142.23M | $142.14M |
| 衍生产品负债 | $185.25M | $34.33M | $18.55M | $18.55M | $5.92M |
| 一年以上递延负债 | $2.35M | $2.35M | $2.35M | $2.35M | $2.35M |
| 其他非流动负债 | $550.19M | $287.52M | $269.65M | $269.65M | $258.99M |
| 股东权益合计 | $2.61B | $1.50B | $1.63B | $1.63B | $1.60B |
| 股东权益 | $2.61B | $1.50B | $1.63B | $1.63B | $1.60B |
| 股本 | $21,000.00 | $19,000.00 | $19,000.00 | $19,000.00 | $18,000.00 |
| -普通股 | $21,000.00 | $19,000.00 | $19,000.00 | $19,000.00 | $18,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $6.58B | $4.82B | $4.50B | $4.50B | $4.10B |
| 留存收益 | -$3.97B | -$3.32B | -$2.87B | -$2.87B | -$2.50B |
| 不影响留存收益的损益 | -$5.95M | -$622,000.00 | $3.24M | $3.24M | $3.12M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$741.48M | -$354.17M | -$897.74M | -$274.24M | -$207.31M |
| 持续经营经营活动现金流净额 | -$741.48M | -$354.17M | -$897.74M | -$274.24M | -$207.31M |
| 持续经营净利润 | -$1.10B | -$453.82M | -$1.13B | -$364.89M | -$305.21M |
| 持续经营损益 | $166.82M | $15.79M | $15.39M | $12.63M | $624,000.00 |
| 折旧、折耗与摊销 | $9.04M | $4.54M | $16.56M | $4.70M | $4.34M |
| 其他非现金项目 | $35.10M | $12.20M | $24.23M | $11.94M | $11.43M |
| 营运资金变动 | -$1.87M | -$16.95M | $86.82M | $32.25M | $56.44M |
| -预付资产变动 | -$59.03M | -$10.09M | -$21.69M | -$10.67M | $6.43M |
| -应付账款及应计费用变动 | $60.93M | $118,000.00 | $121.80M | $44.10M | $64.84M |
| -其他流动负债变动 | -$3.77M | $3.59M | -$420,000.00 | -$1.03M | -$2.11M |
| 投资活动现金流净额 | -$1.49B | $172.62M | $118.06M | $74.88M | $24.85M |
| 持续经营投资活动现金流净额 | -$1.49B | $172.62M | $118.06M | $74.88M | $24.85M |
| 固定资产购置及出售净额 | -$3.82M | -$1.54M | -$15.99M | -$1.93M | -$3.35M |
| 投资购置及出售净额 | -$1.48B | $174.15M | $134.05M | $76.81M | $28.20M |
| 筹资活动现金流 | $2.66B | $238.74M | $621.52M | $365.66M | -$1.59M |
| 持续经营筹资活动现金流净额 | $2.66B | $238.74M | $621.52M | $365.66M | -$1.59M |
| 债务发行及偿还净额 | $487.07M | – | – | – | – |
| 普通股发行净额 | $1.88B | $226.73M | $347.92M | $347.92M | $0.00 |
| 股票期权行使所得 | $49.82M | $12.27M | $273.39M | $261.77M | $4.15M |
| 其他筹资费用净额 | $244.26M | -$252,000.00 | $220,000.00 | -$244.02M | -$5.74M |
| 期末现金余额 | $820.29M | $445.80M | $388.60M | $388.60M | $222.30M |
| 现金净变动 | $431.69M | $57.19M | -$158.16M | $166.30M | -$184.05M |
| 期初现金余额 | $388.60M | $388.60M | $546.76M | $222.30M | $406.35M |
| 自由现金流 | -$745.31M | -$355.70M | -$913.73M | -$276.16M | -$210.66M |
| -其他流动资产变动 | – | -$10.56M | -$12.87M | -$154,000.00 | – |
| -应收款变动 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 RVMD。
登录后参与讨论。